Telomir Pharmaceuticals TELO 深 滬
已收盤 08-15 16:00:00 美东时间
1.49
-0.080
-5.10%
華盛通- 最 高1.56
- 今 開1.52
- 成交量 44.28万股
- 最 低 1.46
- 昨 收 1.57
- 總市值 4434.64万
- 52周最高 8.40
- 市盈率 靜 --
- 換手率 1.49%
- 52周最低 1.12
- 委 比 99.95%
- 總股本 2976.27万
- 歷史最高 20.72
- 量 比 1.04
- 振 幅 6.37%
- 歷史最低 1.12
- 每 手 1
- 風險率 1.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Watching Telomir Pharmaceuticals; Zacks Small-Cap Research Gives Stock $15.50 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_08152025_TELO_Sorensen.pdf
08-16 00:26
Telomir Pharmaceuticals Q2 EPS $(0.17) Misses $(0.08) Estimate
Telomir Pharmaceuticals (NASDAQ:TELO) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.08) by 112.5 percent. This is a 240 percent decrease over losses of $(0.05) per
08-15 04:18
Telomir Pharmaceuticals Unveils Promising In Vitro Data
The latest announcement is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). ...
08-07 20:29
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 151.2% to $3.04 duri...
07-18 20:07
Market-Moving News for July 18th
TELO: 200% | Telomir Pharmaceuticals Announced Earlier, Data Show Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and
07-18 19:13
Telomir Pharmaceuticals Announced Earlier, Data Show Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin
On July 17, 2025, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) reported new preclinical results evaluating the effects of its lead candidate, Telomir-1, in a murine xenograft model using PC3 human prostate
07-18 08:03
Telomir Pharmaceuticals Reveals Promising Preclinical Cancer Results
Telomir Pharmaceuticals, Inc. ( ($TELO) ) has shared an announcement. On July 1...
07-18 04:37
Telo Genomics to Contest Former President’s Lawsuit
The latest announcement is out from Telo Genomics Corp ( ($TSE:TELO) ). Telo Ge...
07-01 07:02
Telomir Pharmaceuticals Reports Positive Preclinical Data
An update from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On J...
06-18 21:53
Telo Genomics Launches Clinical Trial for Enhanced Multiple Myeloma Assessment
An update from Telo Genomics Corp ( ($TSE:TELO) ) is now available. Telo Genomi...
06-18 21:08
